Total Payments
$23,392
2024 Payments
$3,461
Companies
43
Transactions
609
Medicare Patients
5,586
Medicare Billing
$837,469
Payment Breakdown by Category
Food & Beverage$18,486 (79.0%)
Consulting$4,400 (18.8%)
Travel$379.19 (1.6%)
Education$127.54 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,486 | 585 | 79.0% |
| Consulting Fee | $4,400 | 2 | 18.8% |
| Travel and Lodging | $379.19 | 2 | 1.6% |
| Education | $127.54 | 20 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $7,504 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,282 | 102 | $0 (2024) |
| Amgen Inc. | $2,056 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,962 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,835 | 56 | $0 (2024) |
| Lilly USA, LLC | $816.45 | 38 | $0 (2023) |
| Novo Nordisk Inc | $593.45 | 23 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $553.35 | 17 | $0 (2024) |
| Boston Scientific Corporation | $385.27 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $373.92 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,461 | 69 | AstraZeneca Pharmaceuticals LP ($801.67) |
| 2023 | $1,778 | 43 | AstraZeneca Pharmaceuticals LP ($542.90) |
| 2022 | $1,725 | 39 | AstraZeneca Pharmaceuticals LP ($341.11) |
| 2021 | $1,802 | 62 | Boehringer Ingelheim Pharmaceuticals, Inc. ($427.65) |
| 2020 | $798.03 | 26 | Amgen Inc. ($192.65) |
| 2019 | $2,450 | 91 | Gilead Sciences, Inc. ($420.20) |
| 2018 | $5,012 | 133 | Gilead Sciences, Inc. ($2,810) |
| 2017 | $6,367 | 146 | Gilead Sciences Inc ($3,590) |
All Payment Transactions
609 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.77 | General |
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 11/07/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OS | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $120.19 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.61 | General |
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 803 | 3,910 | $260,239 | $135,108 |
| 2022 | 14 | 1,204 | 5,384 | $376,510 | $199,594 |
| 2021 | 18 | 1,447 | 5,726 | $414,331 | $226,170 |
| 2020 | 19 | 2,132 | 7,489 | $583,045 | $276,598 |
Total Patients
5,586
Total Services
22,509
Medicare Billing
$837,469
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 1,186 | $177,900 | $91,338 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 142 | $28,400 | $14,971 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $15,200 | $11,322 | 74.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 108 | 108 | $12,960 | $7,918 | 61.1% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 111 | 187 | $9,350 | $2,965 | 31.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 79 | 80 | $4,000 | $2,536 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $2,400 | $1,727 | 72.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 87 | 89 | $7,120 | $1,207 | 17.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 39 | 39 | $1,170 | $689.91 | 59.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 35 | $1,720 | $419.52 | 24.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 1,920 | $19.20 | $13.63 | 71.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 1,647 | $247,004 | $132,847 | 53.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $22,000 | $17,220 | 78.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 110 | $22,000 | $12,800 | 58.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 132 | 132 | $15,840 | $10,599 | 66.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 99 | 127 | $23,900 | $6,803 | 28.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 18 | $6,840 | $4,644 | 67.9% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 144 | 266 | $13,300 | $4,405 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 101 | 101 | $5,050 | $3,564 | 70.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 109 | 109 | $5,450 | $3,267 | 59.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 126 | 136 | $10,880 | $1,836 | 16.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 45 | 45 | $1,350 | $801.09 | 59.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 49 | $2,450 | $571.52 | 23.3% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 14 | 14 | $420.00 | $219.52 | 52.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 25 | 2,520 | $25.20 | $16.60 | 65.9% |
About Benjamin Wu
Benjamin Wu is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275639502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Wu has received a total of $23,392 in payments from pharmaceutical and medical device companies, with $3,461 received in 2024. These payments were reported across 609 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($18,486).
As a Medicare-enrolled provider, Wu has provided services to 5,586 Medicare beneficiaries, totaling 22,509 services with total Medicare billing of $837,469. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 09/15/2006
- Last Updated 01/15/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275639502
Products in Payments
- Vemlidy (Drug) $5,803
- FARXIGA (Drug) $1,507
- JARDIANCE (Drug) $959.81
- Prolia (Biological) $835.83
- BREZTRI (Drug) $698.66
- AREXVY (Drug) $626.68
- Kerendia (Drug) $553.35
- EVENITY (Biological) $478.41
- ANORO (Drug) $415.01
- Otezla (Drug) $400.08
- TRELEGY ELLIPTA (Drug) $397.98
- XIFAXAN (Drug) $390.58
- XARELTO (Drug) $319.02
- AIRSUPRA (Drug) $312.64
- SYMBICORT (Drug) $301.78
- Repatha (Biological) $271.43
- FASENRA (Biological) $258.05
- Ozempic (Drug) $256.10
- TRADJENTA (Drug) $249.43
- FORTEO (Drug) $238.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Specialist $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Specialist $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Specialist $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Specialist $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Specialist $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649
Specialist $40,649